SG103334A1 - Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole - Google Patents

Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Info

Publication number
SG103334A1
SG103334A1 SG200200477A SG200200477A SG103334A1 SG 103334 A1 SG103334 A1 SG 103334A1 SG 200200477 A SG200200477 A SG 200200477A SG 200200477 A SG200200477 A SG 200200477A SG 103334 A1 SG103334 A1 SG 103334A1
Authority
SG
Singapore
Prior art keywords
methylsulfinyl
pyrrol
benzimidazole
pyridinyl
methoxy
Prior art date
Application number
SG200200477A
Inventor
Kim Dong-Yeun
Park Dong-Woo
Kim Hee-Jun
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Priority to SG200200477A priority Critical patent/SG103334A1/en
Publication of SG103334A1 publication Critical patent/SG103334A1/en

Links

SG200200477A 2002-01-24 2002-01-24 Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole SG103334A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200200477A SG103334A1 (en) 2002-01-24 2002-01-24 Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200200477A SG103334A1 (en) 2002-01-24 2002-01-24 Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Publications (1)

Publication Number Publication Date
SG103334A1 true SG103334A1 (en) 2004-04-29

Family

ID=32653771

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200200477A SG103334A1 (en) 2002-01-24 2002-01-24 Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole

Country Status (1)

Country Link
SG (1) SG103334A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116796A1 (en) * 2020-12-02 2022-06-09 丽珠医药集团股份有限公司 Enteric pellet, preparation method therefor, and preparation comprising same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
US6280773B1 (en) * 1998-12-29 2001-08-28 Il Yang Pharm. Co., Ltd. Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
US6280773B1 (en) * 1998-12-29 2001-08-28 Il Yang Pharm. Co., Ltd. Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116796A1 (en) * 2020-12-02 2022-06-09 丽珠医药集团股份有限公司 Enteric pellet, preparation method therefor, and preparation comprising same

Similar Documents

Publication Publication Date Title
ZA200501084B (en) Dispersible tablets for oral administration
HK1085131A1 (en) Solid drug for oral use
AU3574500A (en) Rapidly disintegrable tablet for oral administration
PL374347A1 (en) Solid pharmaceutical formulations comprising telmisartan
TWI349664B (en) Benzimidazole derivatives: preparation and pharmaceutical applications
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
PT1362582E (en) Enrobed solid dosage form
IL159725A0 (en) Pharmaceutical compositions containing benzimidazole derivatives
GB0210397D0 (en) Pharmaceutical formulations
EP1553925A4 (en) Modified release oral dosage form
NO20054944D0 (en) Cladribine formulations for improved oral and transmucosal administration
TWI319317B (en) Modified release pharmaceutical formulation
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
IS7481A (en) Epothilone for oral administration
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
HK1072194A1 (en) Oral dosage form for controlled drug release
GB2392093B (en) Pharmaceutical formulations
IL165069A0 (en) Immediate release pharmaceutical formulation
PL1673349T3 (en) Benzimidazole derivatives: preparation and pharmaceutical applications
SG103334A1 (en) Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole
EP1652522A4 (en) Sustained release tablet for oral use
EP1491189A4 (en) Diclofenac sodium oral pharmaceutical
SG105539A1 (en) Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules
AU2003254672A8 (en) Dual-spike release formulation for oral drug delivery
GB2394415B (en) Fast dissolving buccal tablets for rapid drug delivery